The TellDx CTC iChip platform enables high-efficiency isolation of intact circulating tumor cells without reliance on cell size or epithelial markers. This unbiased approach is particularly well ...

MediLink Therapeutics has signed an exclusive licensing agreement with Roche for the development and commercialisation of ...

Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges faced by conventional ADCs.

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

The field of immunotherapy has revolutionized the treatment of advanced non-small cell lung cancer (NSCLC), particularly ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

New scientific methods could one day render animal studies—the standard in research laboratories for more than 100 ...

The report, published in Nature, reveals that polyamines bind to specific domains in proteins and operate as a metabolic shield against modifications in their structure. This mechanism is illustrated ...

Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...

The New York-based company, previously known as VantAI and incubated at Roivant before a spinoff, is working in a ...

Cells do more than carry out chemical reactions. New theoretical work suggests they may also generate usable electrical ...

The good news? Robots are no longer reserved for the giant OEMs with endless floor space and million-dollar budgets. Compact, ...